List of patents in the Gene therapy industry

Patents where

Current Assignee

Industry

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7048775 Device and method for monitoring the integrity of filtering installations	Patent 7048775 was granted and assigned to Sartorius on May, 2006 by the United States Patent and Trademark Office.		Sartorius	United States Patent and Trademark Office	7048775	May 23, 2006
‌ US Patent 10155027 Alpha-galactosidase A and 1-deoxygalactonojirimycin co-formulation for the treatment of fabry disease	Patent 10155027 was granted and assigned to Amicus Therapeutics on December, 2018 by the United States Patent and Trademark Office.	Amicus Therapeutics	Amicus Therapeutics	United States Patent and Trademark Office	10155027	December 18, 2018
‌ US Patent 10076514 Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene	Patent 10076514 was granted and assigned to Amicus Therapeutics on September, 2018 by the United States Patent and Trademark Office.	Amicus Therapeutics	Amicus Therapeutics	United States Patent and Trademark Office	10076514	September 18, 2018
‌ US Patent 11833164 Methods of treating Fabry disease in patients having a mutation in the GLA gene	Patent 11833164 was granted and assigned to Amicus Therapeutics on December, 2023 by the United States Patent and Trademark Office.	Amicus Therapeutics	Amicus Therapeutics	United States Patent and Trademark Office	11833164	December 5, 2023
‌ US Patent 11623916 Highly purified batches of pharmaceutical grade migalastat and methods of producing the same	Patent 11623916 was granted and assigned to Amicus Therapeutics on April, 2023 by the United States Patent and Trademark Office.	Amicus Therapeutics	Amicus Therapeutics	United States Patent and Trademark Office	11623916	April 11, 2023
‌ US Patent 10251873 Methods of treating fabry patients having renal impairment	Patent 10251873 was granted and assigned to Amicus Therapeutics on April, 2019 by the United States Patent and Trademark Office.	Amicus Therapeutics	Amicus Therapeutics	United States Patent and Trademark Office	10251873	April 9, 2019
‌ US Patent 10537564 Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene	Patent 10537564 was granted and assigned to Amicus Therapeutics on January, 2020 by the United States Patent and Trademark Office.	Amicus Therapeutics	Amicus Therapeutics	United States Patent and Trademark Office	10537564	January 21, 2020
‌ US Patent 9873894 Methods and compositions for treatment of a genetic condition	Patent 9873894 was granted and assigned to Sangamo Therapeutics on January, 2018 by the United States Patent and Trademark Office.		Sangamo Therapeutics	United States Patent and Trademark Office	9873894	January 23, 2018
‌ US Patent 10357548 α-galactosidase A and 1-deoxygalactonojirimycin co-formulation	Patent 10357548 was granted and assigned to Amicus Therapeutics on July, 2019 by the United States Patent and Trademark Office.	Amicus Therapeutics	Amicus Therapeutics	United States Patent and Trademark Office	10357548	July 23, 2019
‌ US Patent RE48608 Method to predict response to pharmacological chaperone treatment of diseases	Patent RE48608 was granted and assigned to Amicus Therapeutics on June, 2021 by the United States Patent and Trademark Office.	Amicus Therapeutics	Amicus Therapeutics	United States Patent and Trademark Office	RE48608	June 29, 2021
‌ US Patent 11578116 Extracellular vesicles comprising engineered fusion proteins	Patent 11578116 was granted and assigned to Diadem Biotherapeutics on February, 2023 by the United States Patent and Trademark Office.	Diadem Biotherapeutics	Diadem Biotherapeutics	United States Patent and Trademark Office	11578116	February 14, 2023
‌ US Patent 12076420 Adeno-associated virus compositions for restoring PAH gene function and methods of use thereof	Patent 12076420 was granted and assigned to Homology Medicines on September, 2024 by the United States Patent and Trademark Office.	Homology Medicines	Homology Medicines	United States Patent and Trademark Office	12076420	September 3, 2024
‌ US Patent 11326183 VCN enhancer compositions and methods of using the same	Patent 11326183 was granted and assigned to Bluebird Bio on May, 2022 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	11326183	May 10, 2022
‌ US Patent 11633328 Bag containing a biopharmaceutical product and probe holder port for such a product	Patent 11633328 was granted and assigned to Sartorius on April, 2023 by the United States Patent and Trademark Office.	Sartorius	Sartorius	United States Patent and Trademark Office	11633328	April 25, 2023
‌ US Patent 11786516 Methods of treating Fabry patients having renal impairment	Patent 11786516 was granted and assigned to Amicus Therapeutics on October, 2023 by the United States Patent and Trademark Office.	Amicus Therapeutics	Amicus Therapeutics	United States Patent and Trademark Office	11786516	October 17, 2023
‌ US Patent 6861593 Weighing sensor with calibration weight	Patent 6861593 was granted and assigned to Sartorius on March, 2005 by the United States Patent and Trademark Office.		Sartorius	United States Patent and Trademark Office	6861593	March 1, 2005
‌ US Patent 11666564 Methods of treating Fabry patients having renal impairment	Patent 11666564 was granted and assigned to Amicus Therapeutics on June, 2023 by the United States Patent and Trademark Office.	Amicus Therapeutics	Amicus Therapeutics	United States Patent and Trademark Office	11666564	June 6, 2023
‌ US Patent 10471053 Methods of treating Fabry patients having renal impairment	Patent 10471053 was granted and assigned to Amicus Therapeutics on November, 2019 by the United States Patent and Trademark Office.	Amicus Therapeutics	Amicus Therapeutics	United States Patent and Trademark Office	10471053	November 12, 2019
‌ US Patent 11931375 Treatment of amyotrophic lateral sclerosis (ALS)	Patent 11931375 was granted and assigned to Voyager Therapeutics on March, 2024 by the United States Patent and Trademark Office.	Voyager Therapeutics	Voyager Therapeutics	United States Patent and Trademark Office	11931375	March 19, 2024
‌ US Patent 9545450 Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases	Patent 9545450 was granted and assigned to Amicus Therapeutics on January, 2017 by the United States Patent and Trademark Office.		Amicus Therapeutics	United States Patent and Trademark Office	9545450	January 17, 2017
‌ US Patent 8697858 Antisense antiviral compound and method for treating influenza viral infection	Patent 8697858 was granted and assigned to Sarepta Therapeutics on April, 2014 by the United States Patent and Trademark Office.		Sarepta Therapeutics	United States Patent and Trademark Office	8697858	April 15, 2014
‌ US Patent 10267443 Asexual fluid connector having a clamp and protection	Patent 10267443 was granted and assigned to Sartorius on April, 2019 by the United States Patent and Trademark Office.	Sartorius	Sartorius	United States Patent and Trademark Office	10267443	April 23, 2019
‌ US Patent 11407785 Systems and methods for exchange of buffer solutions		‌ Unchained Labs	‌ Unchained Labs	United States Patent and Trademark Office	11407785	August 9, 2022
‌ US Patent 10383864 Methods for treatment of Fabry disease	Patent 10383864 was granted and assigned to Amicus Therapeutics on August, 2019 by the United States Patent and Trademark Office.	Amicus Therapeutics	Amicus Therapeutics	United States Patent and Trademark Office	10383864	August 20, 2019
‌ US Patent 11697801 AAV-mediated delivery of therapeutic antibodies to the inner ear	Patent 11697801 was granted and assigned to Akouos on July, 2023 by the United States Patent and Trademark Office.	Akouos	Akouos	United States Patent and Trademark Office	11697801	July 11, 2023

...

Results per page:

730 results

0 selected

730 results

0 selected